Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As J&J Backs Away From The Altar, Guidant Asks Court For Shotgun Wedding

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson is likely to point to Guidant's weak third quarter sales and earnings as evidence that recent recalls have had a "material adverse effect" on Guidant
Advertisement

Related Content

Boston Scientific Offers $25 Bil. To Nab Guidant From J&J
Boston Scientific Offers $25 Bil. To Nab Guidant From J&J
Guidant Files Lawsuit To Force J&J To Complete Acquisition
New York State Attorney General Files Suit Against Guidant, Alleging Fraud
St. Jude Offers $1.3 Bil. For ANS, Citing Low-Voltage Technology Synergy
Guidant Returns to CRT-D Market With New Supplier For Problem Component
Guidant Returns to CRT-D Market With New Supplier For Problem Component
Advertisement
UsernamePublicRestriction

Register

MT022884

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel